Featured Post
Sprint: Profit From The Short-Term Rallies BP Abbott: New Reasons The Split Could Tank Stock Sirius: New Subscriber High Great For Investors Pfizer: Stable Long-Term Income Stock With Headwinds Likely In The Interim
 
Sprint: Profit From The Short-Term Rallies

Sprint: Profit From The Short-Term Rallies

Sprint (S)is an attractive and potentially lucrative short-term investment. Selling on rallies would be very beneficial for investors interested and willing to buy shares at its current low stock price of less than $3. Sprint’s stock price has ranged from over $2 to under $7 for the last 52 weeks for good reason. This can [...]

BP’s New Recovery Plan Could Generate Upside In 2013

BP’s New Recovery Plan Could Generate Upside In 2013

BP (BP) is now almost two years out from the widely reported 2010 oil rig disaster in the Gulf of Mexico. The massive oil leak hurt the company’s reputation, production levels and cash flow. In the wake of the disaster BP management instituted a new business strategyto rebuild the company and increase returns to shareholders. [...]

Abbott: New Reasons The Split Could Tank Stock

Abbott: New Reasons The Split Could Tank Stock

Abbott Laboratories (ABT) has announcedthat it will split in two by the end of 2012. One half will be a diversified medical products company, while the other will be a research-based pharmaceutical companies. Are the two halves worth more than the whole to investors? And if you buy the company, what is the strategy after [...]

Sirius: New Subscriber High Great For Investors

Sirius: New Subscriber High Great For Investors

Sirius (SIRI) has announced results for a reasonably successful first quarter. Total revenue was $804.2 million from $723.84 million on a year-on-year basis and slightly ahead of consensus estimates of $803.83 million. Net income was $107.77 million or $.02 a share against a $78.12 million or $.01 a share in the same quarter of the [...]

Pfizer: Stable Long-Term Income Stock With Headwinds Likely In The Interim

Pfizer: Stable Long-Term Income Stock With Headwinds Likely In The Interim

Pfizer (PFE) is the world’s largest research based pharmaceutical company by sales. In addition to its core human healthcare business, it has leading positions in animal health care and infant health, as well. I was looking forward to its first quarter 2012 earnings as the company’s top selling drug, Lipitor, lost patent protection in the [...]

AT&T Could Leap $2 Higher By 2013 On Digital Life

AT&T Could Leap $2 Higher By 2013 On Digital Life

19 May 2012

Mobile communication technology is the next big thing as far as the world of finance is concerned. Thus, it is not in the least bit surprising that AT&T (T) is set to move into a bullish direction with its expansion plans. News has it that AT& T is set to diversify into the home security [...]

Read the full story

Posted in Dividend Kings0 Comments

Freeport-McMoRan: Grasberg Violence Could Sink Stock

Freeport-McMoRan: Grasberg Violence Could Sink Stock

19 May 2012

Violence at the giant Grasberg copper and gold mine in Papua, New Guinea, could disrupt Freeport-McMoRan’s operations there and send the mining giant’s stock prices tumbling. The CEO and President of Freeport McMoRan (FCX) made that admission at a conference in Miami on Tuesday. Richard Akderson did not say how his company plans to deal [...]

Read the full story

Posted in Dividend Kings0 Comments

Why Netflix Stinks

Why Netflix Stinks

19 May 2012

Netflix (NFLX) provides and sells subscription services for TV shows and movies, offering customers the choice of receiving DVDs by mail, or streaming its available content through various smart devices in the home. Formerly a popular, high-flying growth stock, peaking near $300 per share in July of 2011, the company and the stock have fallen [...]

Read the full story

Posted in Dividend Kings0 Comments

JPMorgan Mess Will Drive Stock Below $28 This Summer

JPMorgan Mess Will Drive Stock Below $28 This Summer

19 May 2012

In the wake of all the outcries surrounding the woes that have befallen JPMorgan Chase (JPM) in the last couple of days, it becomes increasingly difficult to guess what the future of the company will look like. Nonetheless, it seems a pattern is now arising from all the outcries and it seems that the easiest [...]

Read the full story

Posted in Dividend Kings0 Comments

Silver Wheaton: This $25 Stock Will Boost Your Portfolio Now

Silver Wheaton: This $25 Stock Will Boost Your Portfolio Now

16 May 2012

Silver Wheaton (SLW) is a silver streaming company that operates around the globe to acquire future rights to silver production. If this is lacking in a certain degree of clarity, the company is also referred to as a silver royalty holding company. What each of these seemingly imprecise monikers means is that Silver Wheaton negotiates [...]

Read the full story

Posted in Dividend Kings0 Comments

Why Investors Are Selling GM Like Crazy

Why Investors Are Selling GM Like Crazy

15 May 2012

General Motors (GM) is not an attractive investment at this point in time. Nothing has changed that much with GM since the bailout. Its main rival Ford (F)shows more growth, more potential at a lower discount and a more assertive plan for change. I do not see any silver lining in GM’s current outlook towards [...]

Read the full story

Posted in Dividend Kings0 Comments

4 Big Pharma Stocks To Nab In A Pullback

4 Big Pharma Stocks To Nab In A Pullback

15 May 2012

Patent expiriations aside, acquisitions and new drug launches are boosting earnings. In this article, I’ll show how Big Pharma is back, and explain that the proverbial patent cliffs instead are plateaus for specific drugs facing generic competition. Merck (MRK) beat consensus earnings estimates in the most recent quarter by one cent and continues to enjoy [...]

Read the full story

Posted in Dividend Kings0 Comments

5 Mining Stocks That Could Plummet 15% This Quarter

5 Mining Stocks That Could Plummet 15% This Quarter

15 May 2012

Several miners have hefty headwinds in front of them due to legal and tax challenges coupled with a potentially peaked (for now) gold spot price. Thus, it could be a weak quarter for Agnico-Eagle (AEM), Barrick (ABX), Newmont (NEM), Freeport (FCX) and Vale (VALE), specifically. Agnico-Eagle Mines can now add a class-action lawsuit to the [...]

Read the full story

Posted in Dividend Kings0 Comments

Microsoft Is A Deeply Undervalued Stock At $31

Microsoft Is A Deeply Undervalued Stock At $31

15 May 2012

Microsoft (MSFT) is solid undervalued long-term investment on the market that could increase significantly in stock price within the next few years. Microsoft has innovative technologies on the horizon to regain its leadership in the tech sector once again. Microsoft is also forming powerful partnerships with industry leaders in order to compete with Apple (AAPL) [...]

Read the full story

Posted in Dividend Kings0 Comments

Chimera’s Accounting Woes: Taking A Wait And See Approach For Now

Chimera’s Accounting Woes: Taking A Wait And See Approach For Now

15 May 2012

Chimera (CIM) has announced that Ernst & Young LLP will now be the Independent registered accounting firm and the audit services provided by the current auditor Deloitte & Touche LLP will be concluded after the end of the fiscal year ending 31 December 2011. The company is also reviewing its treatment of its portfolio of [...]

Read the full story

Posted in Dividend Kings0 Comments

 FREE REPORT

This New Gold "Hero Stock" Rescues Your Portfolio From Inflation

Categories